报价延迟最少15分钟:2025/10/23 16:14 EDT
盘后时段
|
||||
|
35.09 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
34.62
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.54/-1.07
|
|
企业价值
2.03B
|
| 资产负债 |
|
每股账面净值
6.93
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
224.50M
|
|
每股收益
2.09
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/10/23 16:14 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S. |
